Clinical

Dataset Information

0

UFT/LEUCOVORIN AND MITOMYCIN C IN THE TREATMENT OF METASTATIC COLORECTAL CANCER OXALIPLATIN AND IRINOTECAN RESISTANT

ABSTRACT: Primary objectives: ACTIVITY OF THE THERAPEUTICAL COMBINATIONS IN TERMS OF OBJECTIVE RESPONSES Primary endpoints: OBJECTIVE RESPONSE

DISEASE(S): Colorectal Cancer Metastatic,Patients With Metastatic Colon-rectal Cancer

PROVIDER: 2523432 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Json Xml

Similar Datasets

Unknown Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapy.
| S-EPMC7983461 | biostudies-literature
Unknown Nanoliposomal irinotecan in combination with leucovorin and 5-fluorouracil in advanced biliary tract cancers.
| S-EPMC8764657 | biostudies-literature
Unknown Using oral tegafur/uracil (UFT) plus leucovorin as adjuvant chemotherapy in stage II colorectal cancer: a propensity score matching study from Taiwan.
| S-EPMC10518963 | biostudies-literature
Unknown Biomarker analysis for patients with pancreatic cancer treated with nanoliposomal irinotecan plus 5-fluorouracil/leucovorin.
| S-EPMC9854093 | biostudies-literature
Unknown Olaparib in combination with irinotecan, cisplatin, and mitomycin C in patients with advanced pancreatic cancer.
| S-EPMC5546463 | biostudies-literature
Unknown Survival predictors in patients with pancreatic cancer on liposomal irinotecan plus fluorouracil/leucovorin: a multicenter observational study.
| S-EPMC11425736 | biostudies-literature
Unknown A pilot study of cisplatin, irinotecan, leucovorin and 5-fluorouracil (PILF) combination chemotherapy for advanced gastric cancer.
| S-EPMC2741674 | biostudies-literature
Clinical FOLFOX 4 + CETUXIMAB IN UNTREATED PATIENTS WITH ADVANCED COLO-RECTAL TUMOUR. A PHASE II MULTICENTER STUDY OF THE GRUPPO ONCOLOGICO DELL’ITALIA MERIDIONALE
| 2516472 | ecrin-mdr-crc
Unknown Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial.
| S-EPMC2990583 | biostudies-literature
Unknown PEPCOL: a GERCOR randomized phase II study of nanoliposomal irinotecan PEP02 (MM-398) or irinotecan with leucovorin/5-fluorouracil as second-line therapy in metastatic colorectal cancer.
| S-EPMC4831286 | biostudies-literature